Showing results 5 to 9 of 9
HS-438, a new inhibitor of Imatinib-resistant BCR-ABL T315I mutation in chronic myeloid leukemia Yun, Sun-Mi; Jung, Kyung Hee; Kim, Soo Jung; Fang, Zhenghuan; Son, Mi Kwon; Yan, Hong Hua; Lee, Hyunseung; et al, CANCER LETTERS, v.348, no.1-2, pp.50 - 60, 2014-06 |
Nanoparticle self-assembly directed by antagonistic kinase and phosphatase activities von Maltzahn, Geoffrey; Min, Dal-Hee; Zhang, Yingxin; Park, Ji-Ho; Harris, Todd J.; Sailor, Michael; Bhatia, Sangeeta N., ADVANCED MATERIALS, v.19, no.21, pp.3579 - 3579, 2007-11 |
Profiling kinase activities by using a peptide chip and mass spectrometry Min, DH; Su, J; Mrksich, M, ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, v.43, no.44, pp.5973 - 5977, 2004 |
Soluble Neuregulin-1 from Microglia Enhances Amyloid Beta-induced Neuronal Death Liew, Hyunjeong; Kim, Yun-Mi; Choi, Hee Soon; Jang, Ah Ram; Churchill, David G; Lee, Sang Hyung; Suh, Yoo-Hun, CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, v.15, no.8, pp.918 - 926, 2016 |
Strategies to overcome acquired resistances conferred by mutations in the kinase domain of EGFR Lim, Sang Min; Jeong, Yujeong; Hong, Sungwoo, FUTURE MEDICINAL CHEMISTRY, v.8, no.8, pp.853 - 878, 2016-05 |
Discover